Home
About Us
Company Profile
Corporate Culture
Milestones
Corporate Honors
Corporate Social Responsibility
Contact Us
Strategy
CSO Platform
Manufacturing Site
R&D Center
Products
Tumor
Cardio-cerebrovascula and Metabolism
Anti-infective
Respiration
Hormone
Immunosuppression
News
Careers
About Us
Company Profile
Corporate Culture
Milestones
Corporate Honors
Corporate Social Responsibility
Contact Us
Strategy
CSO Platform
Manufacturing Site
R&D Center
Products
Tumor
Cardio-cerebrovascula and Metabolism
Anti-infective
Respiration
Hormone
Immunosuppression
News
Careers
简体中文
English
Home
About Us
Company Profile
Corporate Culture
Milestones
Corporate Honors
Corporate Social Responsibility
Contact Us
Strategy
CSO Platform
Manufacturing Site
R&D Center
Products
Tumor
Cardio-cerebrovascula and Metabolism
Anti-infective
Respiration
Hormone
Immunosuppression
News
Careers
Home
About Us
Strategy
Products
News
Careers
中
Home
About Us
Company Profile
Corporate Culture
Milestones
Corporate Honors
Corporate Social Responsibility
Contact Us
Strategy
CSO Platform
Manufacturing Site
R&D Center
Products
Tumor
Cardio-cerebrovascula and Metabolism
Anti-infective
Respiration
Hormone
Immunosuppression
News
Careers
Home
About Us
Strategy
Products
News
Careers
Home
About Us
Company Profile
Corporate Culture
Milestones
Corporate Honors
Corporate Social Responsibility
Contact Us
Strategy
CSO Platform
Manufacturing Site
R&D Center
Products
Tumor
Cardio-cerebrovascula and Metabolism
Anti-infective
Respiration
Hormone
Immunosuppression
News
Careers
Home
About Us
Strategy
Products
News
Careers
En
2023
2022
2021
2020
2023-02-21
Focusing on Children’s Hematological Neoplasms: Promoting Academic Communication and Enc...
Focusing on Children’s Hematological Neoplasms: Promoting Academic Communication and Enc...
Focusing on Children’s Hematological Neoplasms: Promoting Academic Communication and Enc...
2023-02-17
Holding on to the Original Vision After Ten Years, Heading to the Future with High Moral...
Holding on to the Original Vision After Ten Years, Heading to the Future with High Moral...
Holding on to the Original Vision After Ten Years, Heading to the Future with High Moral...
2023-01-20
Haifukang Patient Assistance Program: Benefiting More Than 2,500 Patients
Haifukang Patient Assistance Program: Benefiting More Than 2,500 Patients
Haifukang Patient Assistance Program: Benefiting More Than 2,500 Patients
2023-01-19
Congratulation on Inclusion of Nuzyra® (Omadacycline Tosilate) into 2022 NRDL
Congratulation on Inclusion of Nuzyra® (Omadacycline Tosilate) into 2022 NRDL
Congratulation on Inclusion of Nuzyra® (Omadacycline Tosilate) into 2022 NRDL
2023-01-19
Congratulation on Inclusion of Bilessglu® (Chiglitazar Sodium) into 2022 NRDL
Congratulation on Inclusion of Bilessglu® (Chiglitazar Sodium) into 2022 NRDL
Congratulation on Inclusion of Bilessglu® (Chiglitazar Sodium) into 2022 NRDL
2023-01-18
Ensuring the Supply and Stabilizing the Prize, Putting 200,000 Boxes of Medrol on the E-...
Ensuring the Supply and Stabilizing the Prize, Putting 200,000 Boxes of Medrol on the E-...
Ensuring the Supply and Stabilizing the Prize, Putting 200,000 Boxes of Medrol on the E-...
1
2
>
2023-02-21
Focusing on Children’s Hematological Neoplasms: Promoting Academic Communication and Enc...
Focusing on Children’s Hematological Neoplasms: Promoting Academic Communication and Enc...
Focusing on Children’s Hematological Neoplasms: Promoting Academic Communication and Enc...
2023-02-17
Holding on to the Original Vision After Ten Years, Heading to the Future with High Moral...
Holding on to the Original Vision After Ten Years, Heading to the Future with High Moral...
Holding on to the Original Vision After Ten Years, Heading to the Future with High Moral...
2023-01-20
Haifukang Patient Assistance Program: Benefiting More Than 2,500 Patients
Haifukang Patient Assistance Program: Benefiting More Than 2,500 Patients
Haifukang Patient Assistance Program: Benefiting More Than 2,500 Patients
2023-01-19
Congratulation on Inclusion of Nuzyra® (Omadacycline Tosilate) into 2022 NRDL
Congratulation on Inclusion of Nuzyra® (Omadacycline Tosilate) into 2022 NRDL
Congratulation on Inclusion of Nuzyra® (Omadacycline Tosilate) into 2022 NRDL
2023-01-19
Congratulation on Inclusion of Bilessglu® (Chiglitazar Sodium) into 2022 NRDL
Congratulation on Inclusion of Bilessglu® (Chiglitazar Sodium) into 2022 NRDL
Congratulation on Inclusion of Bilessglu® (Chiglitazar Sodium) into 2022 NRDL
1
2
>
No news added!
No news added!
No news added!
